A systematic market analysis of 201 menopause supplements sold across nine UK retailers and Google Shopping, examining ingredient types, doses, and monthly costs.
Herbs (80.1%), vitamins (76.6%), and phytoestrogens (74.1%) were the dominant ingredient categories; vitamin B6 appeared in 69.2% of products, sage in 42.8%, and red clover in 38.8%. Monthly costs ranged widely from £1.50 to £95, with substantial variability in formulations across products.
No clinical efficacy or safety data were assessed — only market composition was analyzed. The search was limited to UK retailers and may not reflect global availability. Doses and formulations were recorded but not compared against evidence-based thresholds.
Clinicians should ask patients about supplement use and flag that formulations vary enormously in ingredients and cost, often without supporting trial evidence. Menopausal hormone therapy remains the evidence-based first-line option, and shared decision-making should include a clear discussion of the lack of robust data for most supplement ingredients.